Contributing Member of the Healthcare Councils

Names and details of certain GLG News authors are available only to GLG Clients and Council Members. GLG News authors are subject-matter experts within the GLG Councils and are available for expert consulting - by phone, in-person, or written analysis. To find out how to become a GLG client or Council Member, click here.

GLG News by this Author

Analyses are solely the work of the authors and have not been edited or endorsed by GLG.

GLG News is now G+ Insights

G+ is a community for professionals, academics and entrepreneurs to connect through online discussions and in-person meetings. You will continue to see G+ Insights (formerly GLG News) here as well as on the G+ website, where you can share and discuss the G+ Insights you read.

Large study supports sceptics, but unlikely to slow down HPV DNA test market

June 19, 2009

Analysis of:UK Trial Suggests HPV Co-Test Not Significantly Better Than Standard Screening | www.genomeweb.com

1. HPV testing took years to gain acceptance as a co-test with the standard Liquid Based Cytology (LBC) or Pap test. 2. The recent UK research study published in Lancet Oncology appears to support these skeptics... but 3. Due to elevation of HPV DNA testing to the level of standard of care supported by practice guidelines, it is not likely that the UK study will make a significant dent on the market and the manufacturers of HPV tests in the USA. [Analysis is solely the opinion of Author]

Page : 11 to 1 of 1

Subscribe to Updates

By RSS